Equiton: A Private Real Estate Partner Built for Advisors
Equiton offers financial advisors a strategic way to diversify client portfolios with access to high-performing private real estate.
.jpg)
Helping advisors grow client wealth and build stronger practices through private real estate
In a climate where consistent returns are more important than ever, private real estate is gaining attention from forward-thinking advisors and Equiton is at the center of that shift. With a portfolio of over 40 multi-residential properties and the trust of more than 17,000 investors, Equiton is helping financial advisors bring institutional-quality real estate solutions directly to their clients.
What makes Equiton stand out isn’t just its asset base—it’s the exceptional advisor experience. From seamless onboarding and ready-to-use client materials to responsive service and support, Equiton makes it easy for financial advisors to introduce private real estate into their practice. Backed by strong governance, a disciplined financial strategy, and industry-recognized resident satisfaction, Equiton is focused on creating long-term value for both clients and their advisors.
IMPORTANT INFORMATION: This communication is for information purposes only and is not, and under no circumstances is to be construed as, an invitation to make an investment in Equiton Residential Income Fund Trust (the “Fund”) or with Equiton Capital Inc. Recipients of this communication who are considering investing in the Fund are reminded that any such purchase must not be made on the basis of the information contained in this communication but are referred to the Confidential Offering Memorandum which may be obtained upon request. Past performance is not a guarantee of future results.
Watch their video HERE
Published by BTV - The Agency
Discover Investment Opportunities with BTV. Delivering engaging content to Investors for 25+ years.
You might also like
.jpeg)
Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine
Advanced heart failure continues to rise globally, while the supply of donor hearts remains limited. This structural imbalance creates a significant and expanding market opportunity, with thousands of patients each year lacking viable treatment options and placing growing economic pressure on healthcare systems.
